13F Holdings
中文EN

TCG Crossover Management, LLC

PALO ALTO CA · SEC CIK 0001839948

2026Q22026Q1 9 earlier quarters 🔒
$4.16B2026Q2 reported value
54Positions
57.4%Top 10 weight · largest 19.2%
9 / 7New / sold out
Reported value over time$4.16B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

ABVX 19.2%
TNGX 6.8%
CGON 6.3%
COGT 4.5%
IMVT 4.1%
SYRE 4.1%
DNTH 3.9%
MIRM 3.0%
ZLAB 2.8%
AMLX 2.7%

2026Q2 top buys estimated at quarter-end value

ZLAB New+$116.61M
AURA New+$67.69M
AVTX Added+$42.11M
EDIT New+$36.00M
PHVS New+$34.86M

2026Q2 top sells estimated at quarter-end value

CENTESSA PHARMAC Sold out-$170.26M
ABVX Reduced-$63.07M
TNGX Reduced-$45.32M
RVMD Reduced-$44.12M
BHVN Reduced-$42.43M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
ABVX ABIVAX SA AMERICAN DEPOSITARY SHARES $800.60M19.24%6,007,834 -473,251-7.3% -$63.07M Reduced
TNGX TANGO THERAPEUTICS INC $283.88M6.82%9,081,201 -1,449,870-13.8% -$45.32M Reduced
CGON CG ONCOLOGY INC $260.77M6.27%3,670,206 00.0% — Unchanged
COGT COGENT BIOSCIENCES INC $187.87M4.52%4,854,436 -92,458-1.9% -$3.58M Reduced
IMVT IMMUNOVANT INC $171.77M4.13%4,457,988 00.0% — Unchanged
SYRE SPYRE THERAPEUTICS INC $168.73M4.06%1,900,582 00.0% — Unchanged
DNTH DIANTHUS THERAPEUTICS INC $163.44M3.93%1,676,624 00.0% — Unchanged
MIRM MIRUM PHARMACEUTICALS INC $124.33M2.99%1,062,049 00.0% — Unchanged
ZLAB ZAI LAB LTD-ADR $116.61M2.80%6,137,627 6,137,627— $116.61M New
AMLX AMYLYX PHARMACEUTICALS INC $112.14M2.70%6,243,812 00.0% — Unchanged
GLUE MONTE ROSA THERAPEUTICS INC $111.86M2.69%4,622,151 00.0% — Unchanged
BCRX BIOCRYST PHARMACEUTICALS INC $110.21M2.65%11,020,968 00.0% — Unchanged
VOR VOR BIOPHARMA INC $104.44M2.51%5,673,078 00.0% — Unchanged
TYRA TYRA BIOSCIENCES INC $103.77M2.49%3,248,980 00.0% — Unchanged
DYN DYNE THERAPEUTICS INC $102.50M2.46%4,615,144 00.0% — Unchanged
IRON DISC MEDICINE INC $98.14M2.36%1,341,862 00.0% — Unchanged
RLAY RELAY THERAPEUTICS INC $79.95M1.92%4,273,356 00.0% — Unchanged
SVRA SAVARA INC $76.15M1.83%12,362,205 00.0% — Unchanged
AURA AURA BIOSCIENCES INC $67.69M1.63%9,533,333 9,533,333— $67.69M New
RVMD REVOLUTION MEDICINES INC $63.84M1.53%340,899 -235,574-40.9% -$44.12M Reduced
TRAX FIRST TRACKS BIOTHERAPEUTICS $58.25M1.40%2,895,304 2,895,304— — First reported
KOD KODIAK SCIENCES INC $56.32M1.35%1,445,538 00.0% — Unchanged
AVTX AVALO THERAPEUTICS INC $55.76M1.34%3,017,120 2,278,737308.6% $42.11M Added
LBRX LB PHARMACEUTICALS INC $46.97M1.13%1,447,310 -392,179-21.3% -$12.73M Reduced
IPSC CENTURY THERAPEUTICS INC $43.40M1.04%17,754,430 00.0% — Unchanged
TECX TECTONIC THERAPEUTIC INC $41.42M1.00%1,204,891 00.0% — Unchanged
XNCR XENCOR INC $39.48M0.95%2,452,138 00.0% — Unchanged
SRZN SURROZEN INC $38.23M0.92%1,473,101 00.0% — Unchanged
EDIT EDITAS MEDICINE INC $36.00M0.87%11,111,111 11,111,111— $36.00M New
MBX MBX BIOSCIENCES INC $35.88M0.86%650,000 00.0% — Unchanged
PHVS PHARVARIS BV $34.86M0.84%1,008,229 1,008,229— $34.86M New
SLN SILENCE THERAPEUTICS PLC $33.31M0.80%3,033,560 00.0% — Unchanged
IFRX INFLARX N V $32.48M0.78%14,500,000 14,500,000— $32.48M New
ALT ALTIMMUNE INC $30.40M0.73%10,000,000 10,000,000— $30.40M New
JANX JANUX THERAPEUTICS INC $27.49M0.66%1,789,617 00.0% — Unchanged
CATX PERSPECTIVE THERAPEUTICS INC $26.99M0.65%7,915,567 00.0% — Unchanged
AGMB AGOMAB THERAPEUTICS NV $26.65M0.64%2,053,233 00.0% — Unchanged
BHVN BIOHAVEN LTD $26.49M0.64%1,779,952 -2,851,365-61.6% -$42.43M Reduced
AKTS AKTIS ONCOLOGY INC $22.45M0.54%696,560 696,560— $22.45M New
ALEC ALECTOR INC $20.10M0.48%10,000,000 00.0% — Unchanged
— FORTE BIOSCIENCES INC $19.55M0.47%920,000 920,000— $19.55M New
MNPR MONOPAR THERAPEUTICS INC $18.83M0.45%203,327 71,22453.9% $6.59M Added
OCUL OCULAR THERAPEUTIX INC $16.18M0.39%1,647,752 00.0% — Unchanged
— ADC THERAPEUTICS SA $12.19M0.29%11,390,175 00.0% — Unchanged
ALXO ALX ONCOLOGY HOLDINGS INC $11.71M0.28%5,655,487 -7,356,362-56.5% -$15.23M Reduced
TRDA ENTRADA THERAPEUTICS INC $7.80M0.19%1,060,230 -1,227,270-53.7% -$9.03M Reduced
CGEM CULLINAN THERAPEUTICS INC $7.41M0.18%406,786 00.0% — Unchanged
ARVN ARVINAS HOLDING CO LLC $5.88M0.14%707,098 -1,680,363-70.4% -$13.96M Reduced
KRRO KORRO BIO INC $5.49M0.13%416,301 00.0% — Unchanged
— RESEARCH ALLIANCE CORP CL A $5.35M0.13%500,000 500,000— — First reported
— LEONABIO INC $4.27M0.10%464,398 00.0% — Unchanged
— JATT II ACQUISITION CORP $2.27M0.05%200,000 200,000— — First reported
— CONTEXT THERAPEUTICS INC $1.49M0.04%2,682,696 00.0% — Unchanged
EIKN EIKON THERAPEUTICS INC $494,6210.01%37,902 37,902— $494,621 New
— CENTESSA PHARMACEUTICALS PLC $00.00%0 -4,286,480-100.0% -$170.26M Sold out
FULC FULCRUM THERAPEUTICS INC $00.00%0 -5,250,000-100.0% -$40.27M Sold out
LQDA LIQUIDIA TECHNOLOGIES INC $00.00%0 -403,048-100.0% -$15.21M Sold out
URGN UROGEN PHARMA LTD $00.00%0 -405,365-100.0% -$7.29M Sold out
GPCR STRUCTURE THERAPEUTICS INC $00.00%0 -140,411-100.0% -$6.77M Sold out
UPB UPSTREAM BIO INC $00.00%0 -181,063-100.0% -$1.63M Sold out
— VISTAGEN THERAPEUTICS INC $00.00%0 -2,676,580-100.0% -$1.53M Sold out